Neurodegeneration, a progressive decline in the health of nerves, presents a serious challenge to modern medicine. While there is currently no cure for neurodegenerative disorders, researchers are vigorously exploring groundbreaking therapeutic approaches. One such pathway of research involves deschloroketamine, a modified form of the anesthetic ke